ADCs Targeting Embryonic Pluripotent Stem Cell Markers

Mike Schopperle of CureMeta joined us at Americas Antibody Congress 2016 to discuss ‘ADCs targeting embryoninc pluripotent stem cell markers’

Download this presentation to understand more about:

  • Main focus in cancer drug development: oncogenes
  • Common embryonic element present in all cancers
  • CureMeta’s product engine to generate high specificity and high affinity antibodies to embryonic targets.

and much more !

Get your copy here !

If you’re interested in learning more about ADCs and their targets, join us at Americas Antibody Congress 2017 , held May 23-24 in San Diego, CA . This event is co-located with World Biosimilar Congress USA and Cell Culture World Congress USA .

Learn more about Americas Antibody Congress